Aemetis Inc (NASDAQ:AMTX) – Equities research analysts at B. Riley reduced their Q2 2018 earnings per share estimates for Aemetis in a research report issued on Monday, May 14th. B. Riley analyst C. Driscoll now expects that the specialty chemicals company will post earnings per share of ($0.39) for the quarter, down from their prior estimate of ($0.37). B. Riley currently has a “Hold” rating and a $2.00 price target on the stock. B. Riley also issued estimates for Aemetis’ Q3 2018 earnings at ($0.37) EPS, Q4 2018 earnings at ($0.35) EPS, FY2018 earnings at ($1.61) EPS, Q1 2019 earnings at ($0.36) EPS, Q2 2019 earnings at ($0.32) EPS, Q3 2019 earnings at ($0.32) EPS, Q4 2019 earnings at ($0.20) EPS and FY2019 earnings at ($1.20) EPS.
AMTX has been the topic of several other reports. Ascendiant Capital Markets initiated coverage on shares of Aemetis in a report on Tuesday, March 6th. They issued a “buy” rating and a $2.00 price target on the stock. Zacks Investment Research lowered shares of Aemetis from a “hold” rating to a “sell” rating in a report on Tuesday, April 10th.
Aemetis, Inc operates as an international renewable fuels and bio-chemicals company in North America and India. It focuses on the production of advanced fuels and chemicals through the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced bio refineries.
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.